Jefferies Financial Group Inc. Novavax Inc Put Options Transaction History

Jefferies Financial Group Inc.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $70,686 - $112,926	-6,600 Reduced 9.18%	65,300 $824,000
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $25,674 - $138,402	6,600 Added 10.11%	71,900 $910,000
Q1 2024 May 13, 2024	BUY	$3.76 - $6.02 $33,840 - $54,179	9,000 Added 15.99%	65,300 $312,000
Q4 2023 Feb 13, 2024	BUY	$4.8 - $7.67 $270,240 - $431,821	56,300 New	56,300 $270,000
Q4 2022 Sep 21, 2023	BUY	$8.86 - $25.04 $198,464 - $560,896	22,400 New	22,400 $230,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $198,464 - $560,896	22,400 New	22,400 $230,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.